首页> 美国卫生研究院文献>Therapeutic Advances in Musculoskeletal Disease >Minodronate for severe multiple vertebral fractures due to pregnancy- and lactation-associated osteoporosis: a case report and literature review
【2h】

Minodronate for severe multiple vertebral fractures due to pregnancy- and lactation-associated osteoporosis: a case report and literature review

机译:米诺膦酸钠治疗妊娠和哺乳期相关骨质疏松症所致严重多发性椎体骨折的病例报告和文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pregnancy- and lactation-associated osteoporosis (PLO) is a rare type of premenopausal osteoporosis, typically occurring during the third trimester of pregnancy and the early postpartum lactation period. This report presents a case involving severe multiple vertebral fractures due to PLO with low bone mineral density (BMD) and heightened bone turnover. A 39-year-old primiparous Japanese woman reported low back pain (LBP) starting at 28 weeks of pregnancy. The pain temporarily improved after delivery, although the LBP recurred and worsened 2 months into breastfeeding. Thereafter, the patient visited the Obstetrics and Orthopedic departments. Plain radiographs of the thoracic and lumbar spine showed loss of vertebral body height at the T4–12 and L1–3,5 vertebrae, leading to a diagnosis of 13 fractured vertebrae. BMD and serum bone turnover markers revealed low bone density and heightened bone turnover. In the absence of any identified alternative cause of secondary osteoporosis, the diagnosis was severe PLO with 13 vertebral fractures related to pregnancy and lactation. After treatment with bisphosphonates and an active vitamin D analog, the patient exhibited an increased BMD and normalization of bone turnover and resumed regular daily activities. Although the optimal PLO treatment strategy remains uncertain, bisphosphonates are an option; however, bisphosphonates can potentially affect the fetus through placental transfer. Therefore, careful consideration is required for patients planning pregnancy. Despite bisphosphonates’ widespread use and cost-effectiveness, selecting PLO medications involves multiple factors, necessitating further research.
机译:妊娠和哺乳期相关骨质疏松症 (PLO) 是一种罕见的绝经前骨质疏松症,通常发生在妊娠晚期和产后哺乳期早期。本报告介绍了一例涉及骨密度 (BMD) 低和骨转换率升高的 PLO 引起的严重多发性椎体骨折的病例。一名 39 岁的初产妇日本妇女报告从怀孕 28 周开始出现腰痛 (LBP)。分娩后疼痛暂时改善,尽管 LBP 在母乳喂养 2 个月后复发并恶化。此后,患者去了产科和骨科。胸椎和腰椎的 X 线平片显示 T4-12 和 L1-3,5 椎骨的椎体高度下降,导致 13 块椎骨骨折的诊断。BMD 和血清骨转换标志物显示骨密度低和骨转换增加。在没有任何确定的继发性骨质疏松症的其他原因的情况下,诊断为严重的 PLO 伴 13 例与妊娠和哺乳相关的椎骨骨折。在接受双膦酸盐和活性维生素 D 类似物治疗后,患者表现出 BMD 增加和骨转换正常化,并恢复了正常的日常活动。尽管最佳 PLO 治疗策略仍不确定,但双膦酸盐是一种选择;然而,双膦酸盐可能会通过胎盘转移影响胎儿。因此,计划怀孕的患者需要仔细考虑。尽管双膦酸盐广泛使用且具有成本效益,但选择 PLO 药物涉及多种因素,需要进一步研究。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号